Abstract. Hedgehog-binding to Patched family receptors results in Smoothened-mediated activation of MAP3K10 (MST) and inactivation of SUFU. MAP3K10-induced DYRK2 phosphorylation combined with SUFU inhibition results in the stabilization and nuclear accumulation of GLI2 for transcriptional activation of GLI1, CCND1, CCND2, FOXA2, FOXC2, FOXP3, FOXQ1, RUNX2, and JAG2. Here, integrative genomic analyses on GLI2 orthologs were carried out. Rat Gli2 complete coding sequence was determined by assembling nucleotide sequences of exons 1, 2, and 5'-truncated rat Gli2 RefSeq (NM_001107169.1). GLI2 orthologs were more related to GLI3 orthologs than to GLI1 orthologs lacking the N-terminal repressor domain. ßTRCP1 (FBXW1)-binding DSYxxxS motif was conserved in GLI2 and GLI3 orthologs, while ßTRCP2 (FBXW11)-binding DSGxxxxxxxxxS motif in GLI2 and GLI1 orthologs. Human GLI2 mRNA was expressed in ES cells, NT2 cells, fetal lung, fetal heart, regenerating liver, gastric cancer, and other tumors. Mouse Gli2 mRNA was expressed in unfertilized egg, ES cells, and EG cells. Tandem RRRCWWGYYY motifs for P53, P63 or P73, and also four conserved bHLHbinding sites were identified within GLI2 proximal promoter region. Interaction map of P53 and stem cell signaling network were then constructed. P53-induced NOTCH1 upregulation leads to HES1, HES5, HEY1, HEY2 or HEYL upregulation for the repression of tissue specific bHLH transcriptional activators. DYRK2 functions as a positive regulator of P53-mediated apoptosis, and also as a negative regulator of the Hedgehog signaling cascade. GLI2 expression is regulated based on the balance of P53, Notch, and TGF-ß signaling, and Hedgehog signaling activation results in cell survival and proliferation due to transcriptional activation of Hedgehog-target genes, and also partly due to perturbation of P53-mediated transcriptional regulation.
Introduction
Sonic Hedgehog (SHH), Indian Hedgehog (IHH), and Desert Hedgehog (DHH) are Hedgehog family members, regulating embryogenesis, and adult tissue homeostasis, and carcinogenesis (1) (2) (3) (4) (5) . Hedgehog signaling is activated in various human tumors, such as basal cell carcinoma, melanoma, small cell lung cancer, esophageal cancer, gastric cancer, pancreatic cancer, and malignant lymphoma (6) (7) (8) (9) (10) (11) (12) (13) (14) .
Hedgehog precursors are processed to cut off the C-, and N-terminal regions for cholesteroylation and palmitoylation, respectively (15, 16 ). Mature Hedgehog proteins are then transported to the cell surface for DISP1-dependent packaging into lipoprotein particles, or for lipophilic tail-mediated multimerization (16, 17) . PTCH1 and PTCH2 are Hedgehog receptors, while CDON, BOC, and GAS1 are Hedgehog coreceptors (6, (18) (19) (20) . Hedgehog-binding to Patched family receptors results in Smoothened signaling activation due to the Hedgehog-mediated internalization of Patched family receptors suppressing Smoothened function (21, 22) . Hedgehoginduced Smoothened activation leads to MAP3K10 (MST) activation and SUFU inactivation (23, 24) . GLI1, GLI2, and GLI3 constitute the GLI family of transcription factors (25, 26) . GLI1 consists of zinc finger domains, and C-terminal activator domain. On the other hand, GLI2 and GLI3 consist of N-terminal repressor domain, zinc finger domains, and C-terminal activator domain. In the absence of Hedgehog-induced Smoothened activation, GLI1 is transcriptionally repressed, GLI2 is phosphorylated for the ßTRCP2 (FBXW11)-mediated degradation, and GLI3 is phosphorylated for the ßTRCP1 (FBXW1)-mediated processing into repressor lacking the C-terminal activator domain (26) (27) (28) . In the presence of Hedgehog-induced Smoothened activation, MAP3K10 activation and SUFU inactivation leads to the stabilization and nuclear translocation of GLI2, which results in transcriptional activation of target genes, including GLI1, CCND1, CCND2, FOXA2, FOXC2, FOXP3, FOXQ1, RUNX2, and JAG2 (29, 30) . GLI1 upregulation augments the Hedgehog signaling cascades through positive-feedback mechanism, Because transcriptional mechanism of GLI2 remains almost unclear, we carried out integrative genomic analyses on GLI2 orthologs. Complete coding sequence of rat Gli2 was determined for the comparative proteomic analyses. Complete tandem P53-binding sites and four bHLH-binding sites were next identified within proximal promoter region of human GLI2 promoter. Then, interaction map of GLI2 and P53 were constructed with the emphasis on the stem cell signaling network.
Materials and methods
Comparative genomic analyses. Rat genome sequences homologous to human GLI2 and mouse Gli2 were searched for by using the BLAST programs as previously described (31, 32) . Conserved transcription factor-binding sites within promoter regions were then searched for based on the Match program, and manual curation as previously described (33, 34) .
Comparative proteomic analyses. CLUSTALW program was used for phylogenetic analysis on human and rodent GLI family members. Amino-acid sequences of human GLI1 (NP_005260.1), GLI2 (NP_005261.2), GLI3 (NP_000159.3), mouse Gli1 (NP_034426.2), Gli2 (NP_001074594.1), Gli3 (NP_032156.2), and rat Gli2 ( Fig. 1) were used for the phylogenetic analysis.
In silico expression analyses. Expressed sequence tags (ESTs) derived from human GLI2 and mouse Gli2 were searched for using the BLAST programs as previously described (35, 36) . Human GLI2 RefSeq (NM_005270.3) and mouse Gli2 RefSeq (NM_001081125.1) were used as query sequences for the BLAST programs.
Results
Complete coding sequence of rat Gli2. Preliminary phylogenetic analyses on the mammalian GLI family members revealed that rat Gli2 protein RefSeq (NP_001100639.1) deduced from rat Gli2 nucleotide RefSeq (NM_001107169.1) was N-terminally truncated. Comparative genomic analyses next revealed that the 5'-truncation of NM_001107169.1 RefSeq was due to the lack of nucleotide sequences corresponding to exons 1 and 2 of rat Gli2 gene. Therefore, we decided to determine the complete coding sequence of rat Gli2 transcript in this study.
BLAST programs revealed that missing exons 1 and 2 of the rat Gli2 gene were located within rat genome sequence AC120834. was the coding region of rat Gli2 complete coding sequence, rat Gli2 gene was found to encode 1544 amino-acid Gli2 protein (Fig. 1A) .
Comparative proteomics on mammalian GLI family members.
Refined phylogenetic analysis on the GLI family members using the full-length rat Gli2 protein revealed that GLI2 orthologs were more related to GLI3 orthologs than to GLI1 orthologs (Fig. 1B) . Alignment of mammalian GLI family members next revealed that GLI1 orthologs were shorter than GLI2 and GLI3 orthologs due to the lack of the N-terminal repressor domain.
Bhatia et al reported that DSGxxxxxxxxxS motif in GLI2 orthologs is the ßTRCP2-binding site to induce degradation (27) , and Tempé et al reported that DSYxxxS motif in Gli3 is the ßTRCP1-binding site to induce proteolysis (28) . We found that the DSGxxxxxxxxxS motif was conserved in GLI2 and GLI1 orthologs, and also that the DSYxxxS motif was conserved in GLI2 and GLI3 orthologs (Fig. 1C and D) .
Expression profile of GLI2 orthologs. Human
GLI2 mRNA was expressed in ES cells, NT2 cells, fetal lung, fetal heart, regenerating liver, gastric cancer, ovarian cancer, prostate cancer, acute myelogenous leukemia, neuroblastoma, and glioblastoma. Mouse Gli2 mRNA was expressed in unfertilized egg, ES cells, and EG cells.
Comparative genomics on mammalian GLI2 orthologs.
Because the nucleotide sequence of proximal promoter region of rat Gli2 gene was homologous to 5'-region of human GLI2 exon 1a rather than that of exon 1b, comparative genomic analyses were focused on the 5'-region of human GLI2 exon 1a in this study.
Transcription factor-binding sites within the 5'-region of human GLI2 exon 1a were then searched for. Although it was previously reported that TGFß induces Smad3-mediated GLI2 upregulation in human fibroblasts, keratinocytes, and various cancer cell lines (37), Smad3-binding site within the 5'-region of human GLI2 exon 1a was not successfully identified due to the too redundant sequences of Smad-3-binding sites. Instead, basic helix-loop-helix (bHLH)-binding sites, and tandem RRRCWWGYYY motifs without any space for P53, P63 or P73 transcription factors were identified within the 1.5-kb region just upstream of the transcriptional start site of human GLI2 exon 1a ( Fig. 2A) . Four basic helix-loop-helix (bHLH)-binding sites within human GLI2 promoter were conserved in the mouse Gli2 promoter.
Tandem P53-binding motifs within human GLI2 promoter were not conserved in rodents due to significant regional divergence, and not in chimpanzee due to C>T nucleotide substitution at the consensus C residue of the first P53-binding motif. Because the tandem P53-binding motifs within the GLI2 promoter were destroyed in chimpanzee GLI2 promoter due to single nucleotide substitution, we next searched for a single nucleotide polymorphism (SNP) at that position. However, we could not detect any SNP at the P53-binding site within GLI2 promoter at least in AC017033.5 and AC016764.8 BAC sequences and personal genome sequences of Dr Venter and Dr Watson.
Together these facts indicate that four bHLH-binding sites within GLI2 promoter were evolutionarily conserved, and that the tandem P53-binding motifs within the GLI2 promoter were human specific.
Interaction map of P53 with stem cell signaling network.
Hedgehog, BMP/TGFß/Nodal/Activin, EGF/FGF, Notch, and WNT signaling cascades constitute stem cell signaling network (3, (38) (39) (40) (41) . Because both P53 and stem cell signaling network are implicated in carcinogenesis, we next constructed the interaction map of P53 with stem cell signaling network.
P53-induced Notch1 upregulation (42, 43) leads to upregulation of Hes/Hey family members to repress tissue specific bHLH transcriptional activators (36, (44) (45) (46) . bHLH and P53 are predicted to regulate GLI2 transcription ( Fig. 2A) , and TGF-ß signaling to Smad3 is also implicated in GLI2 upregulation as mentioned above (37) . Together these facts indicate that GLI2 expression is regulated based on the balance of P53, Notch, and TGF-ß signaling (Fig. 2B) .
We cloned and characterized MAP3K10 (MST) as a novel serine/threonine kinase derived from MKN28 gastric cancer cells in 1995 (47) , and Taipale's group identified MAP3K10 as a Hedgehog signaling component in 2008 (23) . MAP3K10 is reported to directly phosphorylate DYRK2 for its functional inhibition (23) . DYRK2 functions as a negative regulator of the Hedgehog signaling cascade (23), but also as a positive regulator of P53-mediated apoptosis (24) . GLI2-mediated Hedgehog signaling activation results in cell survival and proliferation due to transcriptional activation of Hedgehogtarget genes, and also partly due to perturbation of P53-mediated transcriptional regulation (Fig. 2B) .
Discussion
Complete coding sequence of rat Gli2 was determined in this study (Fig. 1A) . GLI2 and GLI3 orthologs shared the common domain architecture, consisting of N-terminal repressor domain, zinc finger domains, ßTRCP1-binding DSYxxxS motif, and C-terminal activator domain (Fig. 1C) .
Although GLI2 orthologs were more related to GLI3 orthologs than to GLI1 orthologs, ßTRCP2-binding DSGxxxxx xxxxS motif was conserved in GLI2 and GLI1 orthologs, but not in GLI3 orthologs (Fig. 1C) . DYRK2, PKA and GSK3ß phosphorylate GLI2 in the absence of Hedgehog signaling (23, 48) , and phosphorylation of the DSGxxxxxxxxxS motif in GLI2 leads to ßTRCP2-mediated ubiquitination and subsequent proteasome-dependent degradation (27) . In the absence of Hedgehog signaling, GLI1 mRNA is transcriptionally repressed, and GLI1 protein might also be degraded due to the same mechanism as GLI2 degradation. We identified tandem P53-binding motifs within the human GLI2 promoter (Fig. 2A) . GLI2 was not listed on the 542 target genes or loci of P53 identified by using ChIP-on-PET approach (42) , nor on the 1546 targets of P53 identified by using ChIP-on-chip approach (49) . P53, P63, and P73 bind to the tandem RRRCWWGYYY motifs to activate or repress their target genes. Although transcriptional regulation of GLI2 by P53, P63, and P73 should be further investigated, this is the first report on the tandem P53-binding motifs within the proximal promoter region of human GLI2 gene.
DYRK2 phosphorylates P53 to enhance apoptotic response to DNA damage (50), while DYRK2 phosphorylates GLI2 and NFATc to prime subsequent phosphorylation by GSK3ß for degradation and inhibition of nuclear translocation, respectively (23, 51) . Hedgehog signaling activation leads to DYRK2 inhibition in the cytoplasm, which might lead to inhibition of DYRK2-mediated P53 activity in the nucleus. Because DYRK2, HIPK2, PKCδ and P38 are implicated in P53 activation (50) , Hedgehog signals are predicted to partially inhibit P53 activity in cancer cells.
It was expected that DYRK2 gene might be deleted, mutated or silenced in some cancer as a tumor suppressor gene; however, DYRK2 gene is amplified and overexpressed in lung cancer, esophageal cancer, and gastric cancer (52,53).
The mechanism how DYRK2 overexpression leads to survival or proliferation of tumor cells remains to be elucidated.
MDM2 and MDM4 (MDMX) are negative regulators of P53. MDM2 and MDM4 share the common domain architecture consisting of P53-binding domain, acidic domain, zinc finger domain, and RING finger domain (54) (55) (56) (57) . MDM2 gene, located at human chromosome 12q15, is amplified and overexpressed in osteosarcoma, soft tissues sarcoma, gastric cancer, lung cancer, and esophageal cancer (52, 55, 58) . MDM4 gene, located at human chromosome 1q32.1, is amplified and overexpressed in malignant glioma, breast cancer, and retinoblastoma (59) (60) (61) . MDM2 and MDM4 function as oncogenes, because MDM2 and MDM4 proteins protect tumor cells from apopotosis or growth arrest due to their inhibitory effect on P53 tumor suppressor.
Receptor tyrosine kinase (RTK)-mediated or RTK-induced PI3K-AKT signaling activation leads MDM2 phosphorylation at Ser 166 and Ser 186 to inhibit P53 activity (62) . Because the activation of Hedgehog signaling and RTK signaling synergistically inhibits P53 function (Fig. 2B) , monitoring of P53, Hedgehog, and AKT activities in primary tumors could be utilized for the prediction of effectiveness of DNA-damaging agent or irradiation to induce P53-mediated apoptosis in cancer cells. In addition, combination chemotherapy using 
